Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Vulvar Neoplasms × tremelimumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Prostatic Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Recurrent Squamous Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Mesothelioma 2 Lung Neoplasms 2 Liver Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Testicular Neoplasms 1 Solid Tumor 1 Sarcoma, Synovial 1

Interventions

Platinum 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Cisplatin 2 Biopsy 2 1,2-diaminocyclohexaneplatinum II citrate 2 fludarabine phosphate 1 fludarabine 1 alovudine 1 aldesleukin 1 Vaccines, Synthetic 1 Sonazoid 1 Respiratory Function Tests 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1 Prochlorperazine 1 Positron-Emission Tomography 1 Ondansetron 1 O(6)-codeine methyl ether 1 Meperidine 1 Magnetic Resonance Imaging 1 Loperamide 1 Interleukin-2 1 Innovar 1 Indomethacin 1 Imiquimod 1 Hydroxyzine 1 Granisetron 1 Gemcitabine 1 Fondaparinux 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡